These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21626300)

  • 1. Association between Epstein-Barr virus infection and chemoresistance to docetaxel in gastric carcinoma.
    Shin HJ; Kim DN; Lee SK
    Mol Cells; 2011 Aug; 32(2):173-9. PubMed ID: 21626300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of Epstein-Barr virus infection to chemoresistance of gastric carcinoma cells to 5-fluorouracil.
    Seo JS; Kim TG; Hong YS; Chen JY; Lee SK
    Arch Pharm Res; 2011 Apr; 34(4):635-43. PubMed ID: 21544729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suberoylanilide hydroxamic acid induces viral lytic cycle in Epstein-Barr virus-positive epithelial malignancies and mediates enhanced cell death.
    Hui KF; Chiang AK
    Int J Cancer; 2010 May; 126(10):2479-89. PubMed ID: 19816947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression.
    Zheng X; Wang J; Wei L; Peng Q; Gao Y; Fu Y; Lu Y; Qin Z; Zhang X; Lu J; Ou C; Li Z; Zhang X; Liu P; Xiong W; Li G; Yan Q; Ma J
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30209170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.
    Abdulkarim B; Sabri S; Zelenika D; Deutsch E; Frascogna V; Klijanienko J; Vainchenker W; Joab I; Bourhis J
    Oncogene; 2003 Apr; 22(15):2260-71. PubMed ID: 12700662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir.
    Hui KF; Cheung AK; Choi CK; Yeung PL; Middeldorp JM; Lung ML; Tsao SW; Chiang AK
    Int J Cancer; 2016 Jan; 138(1):125-36. PubMed ID: 26205347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Screen for Epstein-Barr Virus Proteins That Inhibit the DNA Damage Response Reveals a Novel Histone Binding Protein.
    Ho TH; Sitz J; Shen Q; Leblanc-Lacroix A; Campos EI; Borozan I; Marcon E; Greenblatt J; Fradet-Turcotte A; Jin DY; Frappier L
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-encoded BARF1 promotes proliferation of gastric carcinoma cells through regulation of NF-κB.
    Chang MS; Kim DH; Roh JK; Middeldorp JM; Kim YS; Kim S; Han S; Kim CW; Lee BL; Kim WH; Woo JH
    J Virol; 2013 Oct; 87(19):10515-23. PubMed ID: 23824821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma.
    Sivachandran N; Dawson CW; Young LS; Liu FF; Middeldorp J; Frappier L
    J Virol; 2012 Jan; 86(1):60-8. PubMed ID: 22013060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-cycle regulators, bcl-2 and NF-kappaB in Epstein-Barr virus-positive gastric carcinomas.
    Chang MS; Lee HS; Jung EJ; Kim CW; Lee BL; Kim WH
    Int J Oncol; 2005 Nov; 27(5):1265-72. PubMed ID: 16211221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Epstein-Barr Virus Genomes and Expression Profiles in Gastric Adenocarcinoma.
    Borozan I; Zapatka M; Frappier L; Ferretti V
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide identification of Epstein-Barr virus-driven promoter methylation profiles of human genes in gastric cancer cells.
    Zhao J; Liang Q; Cheung KF; Kang W; Lung RW; Tong JH; To KF; Sung JJ; Yu J
    Cancer; 2013 Jan; 119(2):304-12. PubMed ID: 22833454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olaparib-induced Apoptosis Through EBNA1-ATR-p38 MAPK Signaling Pathway in Epstein-Barr Virus-positive Gastric Cancer Cells.
    Moon SH; Park NS; Noh MH; Kim YS; Cheong SH; Hur DY
    Anticancer Res; 2022 Jan; 42(1):555-563. PubMed ID: 34969765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted therapy for Epstein-Barr virus-associated gastric carcinoma using low-dose gemcitabine-induced lytic activation.
    Lee HG; Kim H; Kim EJ; Park PG; Dong SM; Choi TH; Kim H; Chong CR; Liu JO; Chen J; Ambinder RF; Hayward SD; Park JH; Lee JM
    Oncotarget; 2015 Oct; 6(31):31018-29. PubMed ID: 26427042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment and characterization of two Epstein-Barr virus-positive gastric cancer cell lines with epitheliotropic M81 strain undergoing distinct viral and altered cellular expression profiles.
    Xu M; Zhang L; Feng J; Yang S; Wang Y; Wang Y; Chen M; Zhou L; Zhang J; Qin Q
    J Med Virol; 2023 Jan; 95(1):e28387. PubMed ID: 36478267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproic acid enhances the efficacy of chemotherapy in EBV-positive tumors by increasing lytic viral gene expression.
    Feng WH; Kenney SC
    Cancer Res; 2006 Sep; 66(17):8762-9. PubMed ID: 16951192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus and gastric carcinoma: virus-host interactions leading to carcinoma.
    Fukayama M; Hino R; Uozaki H
    Cancer Sci; 2008 Sep; 99(9):1726-33. PubMed ID: 18616681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EBNA1 inhibitors have potent and selective antitumor activity in xenograft models of Epstein-Barr virus-associated gastric cancer.
    Soldan SS; Anderson EM; Frase DM; Zhang Y; Caruso LB; Wang Y; Deakyne JS; Gewurz BE; Tempera I; Lieberman PM; Messick TE
    Gastric Cancer; 2021 Sep; 24(5):1076-1088. PubMed ID: 33929613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma.
    Hui KF; Ho DN; Tsang CM; Middeldorp JM; Tsao GS; Chiang AK
    Int J Cancer; 2012 Oct; 131(8):1930-40. PubMed ID: 22261816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc finger E-box binding factor 1 plays a central role in regulating Epstein-Barr virus (EBV) latent-lytic switch and acts as a therapeutic target in EBV-associated gastric cancer.
    Zhao J; Jin H; Cheung KF; Tong JH; Zhang S; Go MY; Tian L; Kang W; Leung PP; Zeng Z; Li X; To KF; Sung JJ; Yu J
    Cancer; 2012 Feb; 118(4):924-36. PubMed ID: 21717425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.